Company Profile: Contego Medical, LLC

CED Life Science Conference 2017 - Showcase                                                           
Sub-sector: Medical Device                                                               
Year Founded: 2013

Contego Medical, LLC is a commercial stag medical device company dedicated to the development of novel devices to improve cardiovascular outcomes. The company’s Integrated Embolic Protection (IEP) platform, which combines embolic protection and treatment into one device, is designed to simplify and improve outcomes during catheter-based procedures. Contego Medical’s portfolio is poised to transform cardiovascular and endovascular interventions by making existing procedures safer without increasing complexity or compromising performance. The company is focused on three initial products with Integrated Embolic Protection: The Paladin® Carotid Post-Dilation Balloon System, the first and only angioplasty balloon with IEP technology aimed at reducing stroke risk, the Vanguard IEP® Peripheral Balloon Angioplasty System and the Corguard® Coronary Sirolimus-Eluting Stent System.

Ravish Sachar MD, CEO
David Stern, COO
Nathalie Greene, Vice President of Finance
Joop Meijer, Vice President of European Sales
Elizabeth Saylors, Vice President of Quality and Clinical Affairs


  • Funding: $9.6MM through Series B
  • CE Mark and commercialization of Paladin System
  • CE Mark of Vanguard IEP System
  • Completion of  the Paladin System clinical study with best-in-class data to date
  • EMEA distribution agreement with a large multinational company

CED, North Carolina Biotechnology Center

Nathalie Greene
Raleigh, NC

Learn more about the CED Life Science Conference.